Tang Capital Management as of Dec. 31, 2022
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 89 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Anaptysbio Inc Common (ANAB) | 11.8 | $82M | 2.6M | 30.99 | |
| Altimmune Com New (ALT) | 6.5 | $44M | 2.7M | 16.45 | |
| Bluebird Bio (BLUE) | 4.7 | $32M | 4.6M | 6.92 | |
| Tarsus Pharmaceuticals (TARS) | 4.3 | $29M | 2.0M | 14.66 | |
| Bioatla (BCAB) | 3.7 | $26M | 3.1M | 8.25 | |
| Alnylam Pharmaceuticals (ALNY) | 3.6 | $25M | 105k | 237.65 | |
| Axsome Therapeutics (AXSM) | 3.6 | $25M | 320k | 77.13 | |
| Immunocore Hldgs Ads (IMCR) | 3.4 | $23M | 406k | 57.07 | |
| Mirum Pharmaceuticals (MIRM) | 3.2 | $22M | 1.1M | 19.50 | |
| Kalvista Pharmaceuticals (KALV) | 3.1 | $22M | 3.2M | 6.76 | |
| Miragen Therapeutics (VRDN) | 2.9 | $20M | 693k | 29.21 | |
| Beigene Sponsored Adr | 2.7 | $19M | 85k | 219.94 | |
| BioCryst Pharmaceuticals (BCRX) | 2.4 | $17M | 1.5M | 11.48 | |
| Harmony Biosciences Hldgs In (HRMY) | 2.3 | $16M | 281k | 55.10 | |
| Vaxcyte (PCVX) | 2.1 | $14M | 300k | 47.95 | |
| Moderna (MRNA) | 2.1 | $14M | 80k | 179.62 | |
| Intra Cellular Therapies (ITCI) | 1.8 | $13M | 240k | 52.92 | |
| Astrazeneca Sponsored Adr (AZN) | 1.7 | $12M | 170k | 67.80 | |
| Nkarta (NKTX) | 1.6 | $11M | 1.9M | 5.99 | |
| Heron Therapeutics (HRTX) | 1.4 | $9.4M | 3.8M | 2.50 | |
| Enanta Pharmaceuticals (ENTA) | 1.4 | $9.3M | 200k | 46.52 | |
| Kiniksa Pharmaceuticals Com Cl A | 1.3 | $9.0M | 600k | 14.98 | |
| Albireo Pharma | 1.3 | $8.9M | 412k | 21.61 | |
| Bio Rad Labs Cl A (BIO) | 1.3 | $8.8M | 21k | 420.49 | |
| Cullinan Oncology (CGEM) | 1.2 | $8.5M | 809k | 10.55 | |
| Ionis Pharmaceuticals (IONS) | 1.1 | $7.6M | 200k | 37.77 | |
| Eli Lilly & Co. (LLY) | 1.1 | $7.3M | 20k | 365.84 | |
| Third Harmonic Bio (THRD) | 1.1 | $7.3M | 1.7M | 4.30 | |
| Concert Pharmaceuticals I equity | 1.0 | $6.7M | 1.2M | 5.84 | |
| ImmunoGen | 0.9 | $6.3M | 1.3M | 4.96 | |
| Evolus (EOLS) | 0.9 | $6.1M | 810k | 7.51 | |
| Cytomx Therapeutics (CTMX) | 0.8 | $5.6M | 3.5M | 1.60 | |
| Adicet Bio (ACET) | 0.8 | $5.4M | 600k | 8.94 | |
| Genfit S A Ads (GNFT) | 0.8 | $5.3M | 1.2M | 4.39 | |
| Galapagos Nv Spon Adr (GLPG) | 0.7 | $5.1M | 115k | 44.38 | |
| Cytokinetics Com New (CYTK) | 0.7 | $5.0M | 110k | 45.82 | |
| Pyxis Oncology Common Stock (PYXS) | 0.7 | $4.7M | 3.5M | 1.34 | |
| Biontech Se Sponsored Ads (BNTX) | 0.7 | $4.5M | 30k | 150.22 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.6 | $4.4M | 36k | 122.13 | |
| Alibaba Group Hldg Sponsored Ads (BABA) | 0.6 | $4.4M | 50k | 88.09 | |
| Iteos Therapeutics (ITOS) | 0.6 | $4.2M | 217k | 19.53 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.6 | $3.9M | 393k | 9.98 | |
| Allakos (ALLK) | 0.5 | $3.8M | 448k | 8.42 | |
| Beam Therapeutics (BEAM) | 0.5 | $3.7M | 95k | 39.11 | |
| Amylyx Pharmaceuticals (AMLX) | 0.5 | $3.7M | 100k | 36.95 | |
| Graphite Bio | 0.5 | $3.7M | 1.1M | 3.32 | |
| Silverback Therapeutics (SPRY) | 0.5 | $3.5M | 410k | 8.53 | |
| Eagle Pharmaceuticals (EGRX) | 0.5 | $3.5M | 119k | 29.23 | |
| Insmed Com Par $.01 (INSM) | 0.5 | $3.3M | 166k | 19.98 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.5 | $3.2M | 300k | 10.64 | |
| Zymeworks Del (ZYME) | 0.5 | $3.1M | 400k | 7.86 | |
| Arcus Biosciences Incorporated (RCUS) | 0.4 | $3.1M | 148k | 20.68 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.4 | $3.0M | 60k | 49.92 | |
| Tcr2 Therapeutics Inc cs | 0.4 | $2.7M | 2.7M | 1.00 | |
| Mirati Therapeutics | 0.4 | $2.7M | 60k | 45.31 | |
| Aligos Therapeutics | 0.4 | $2.7M | 2.8M | 0.95 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.4 | $2.6M | 246k | 10.50 | |
| 2seventy Bio Common Stock (TSVT) | 0.3 | $2.3M | 250k | 9.37 | |
| Biohaven (BHVN) | 0.3 | $1.9M | 140k | 13.88 | |
| Aslan Pharmaceuticals Ads | 0.3 | $1.9M | 5.4M | 0.36 | |
| Metacrine Ord | 0.3 | $1.9M | 4.3M | 0.45 | |
| Aldeyra Therapeutics (ALDX) | 0.3 | $1.9M | 272k | 6.96 | |
| Cti Biopharma | 0.3 | $1.8M | 300k | 6.01 | |
| Tonix Pharmaceuticals Hldg C Com New | 0.3 | $1.8M | 4.5M | 0.39 | |
| Blueprint Medicines (BPMC) | 0.3 | $1.8M | 40k | 43.81 | |
| Athira Pharma (ATHA) | 0.2 | $1.5M | 485k | 3.17 | |
| Arvinas Ord (ARVN) | 0.1 | $1.0M | 30k | 34.21 | |
| Celldex Therapeutics Com New (CLDX) | 0.1 | $945k | 21k | 44.57 | |
| Coherus Biosciences (CHRS) | 0.1 | $918k | 116k | 7.92 | |
| Sio Gene Therapies | 0.1 | $870k | 2.0M | 0.43 | |
| Aurinia Pharmaceuticals (AUPH) | 0.1 | $864k | 200k | 4.32 | |
| Tscan Therapeutics (TCRX) | 0.1 | $798k | 515k | 1.55 | |
| Olema Pharmaceuticals (OLMA) | 0.1 | $781k | 319k | 2.45 | |
| Orchard Therapeutics Spon Ads | 0.1 | $742k | 2.0M | 0.37 | |
| Bolt Biotherapeutics (BOLT) | 0.1 | $520k | 400k | 1.30 | |
| Elevation Oncology (ELEV) | 0.1 | $456k | 480k | 0.95 | |
| Acelrx Pharmaceuticals Com New (TLPH) | 0.1 | $441k | 195k | 2.26 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.1 | $407k | 10k | 40.65 | |
| Nektar Therapeutics (NKTR) | 0.1 | $371k | 164k | 2.26 | |
| Surface Oncology | 0.1 | $352k | 430k | 0.82 | |
| Relmada Therapeutics (RLMD) | 0.1 | $349k | 100k | 3.49 | |
| Atyr Pharma Com New (ATYR) | 0.0 | $270k | 123k | 2.19 | |
| Gossamer Bio (GOSS) | 0.0 | $217k | 100k | 2.17 | |
| Molecular Partners Ads (MOLN) | 0.0 | $144k | 22k | 6.55 | |
| Vincerx Pharma Com New (VINC) | 0.0 | $104k | 102k | 1.02 | |
| Reviva Pharmaceutcls Hldgs I (RVPH) | 0.0 | $103k | 24k | 4.25 | |
| Lianbio Sponsored Ads (LIANY) | 0.0 | $98k | 60k | 1.64 | |
| Reneo Pharmaceuticals (RPHM) | 0.0 | $71k | 31k | 2.33 | |
| Pardes Biosciences | 0.0 | $57k | 34k | 1.69 |
